- Trials with a EudraCT protocol (6)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
6 result(s) found for: Peristalsis.
Displaying page 1 of 1.
EudraCT Number: 2019-002187-26 | Sponsor Protocol Number: neostigmine2019 | Start Date*: 2019-08-28 |
Sponsor Name:KU Leuven - TARGID | ||
Full Title: A Prospective evaluation of the effect of a single dose of neostigmine in patients with patients with weak or absent esophageal peristalsis | ||
Medical condition: Patients with complaints of dysphagia and poor esophageal motility | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001145-14 | Sponsor Protocol Number: 2012.779 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Traitement endoscopique de l’œsophage hypercontractile par injection de toxine botulinique : étude prospective, randomisée, contrôlée en double aveugle | |||||||||||||
Medical condition: Œsophage hypercontractile | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004723-17 | Sponsor Protocol Number: UZBSK001 | Start Date*: 2021-02-26 |
Sponsor Name:UZ Brussel | ||
Full Title: Clinical usefulness and influence on oesophageal motility of pyridostigmine for dysphagia in systemic sclerosis. | ||
Medical condition: Dysphagia by patients suffering from systemic sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002182-35 | Sponsor Protocol Number: buspirone2019 | Start Date*: 2019-09-10 |
Sponsor Name:KU Leuven - TARGID | ||
Full Title: The effect of oral buspirone hydrochloride on esophageal motility, bolus transit and symptoms of dysphagia, in patients with poor esophageal motility: A randomized, double-blind, placebo controlle... | ||
Medical condition: Patients with complaints of dysphagia and poor esophageal motility | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000782-36 | Sponsor Protocol Number: AGO/2013/002 | Start Date*: 2013-08-13 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: Effect of TachoSil® on incidence of symptomatic and radiographic lymphoceles after extended pelvic lymph node dissection in prostate and bladder cancer. | |||||||||||||
Medical condition: Patients with prostate cancer or bladder cancer, undergoing transperitoneal pelvic lymph node dissection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001202-14 | Sponsor Protocol Number: CiPA001 | Start Date*: 2019-06-05 |
Sponsor Name:Amsterdam UMC | ||
Full Title: CiPA Trial: Effect of Citalopram on chest pain in patients with achalasia | ||
Medical condition: Achalasia is a motility disorder of the esophagus. Disappearance of myenteric neurons in the esophageal wall leads to failure of relaxation of the lower esophageal sphincter (LES) and impaired peri... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
